iX Biopharma
Sublingual pharmaceutical wafers and nutraceutical products.
iX Biopharma manufactures sublingual pharmaceutical wafers and nutraceutical products from its Singapore operations. The company supplies healthcare systems, laboratories, OEM partners or regulated export customers across its listed primary markets.
- Type
- Manufacturer
- Location
- Singapore
- Founded
- 2008
- Website
- ixbiopharma.com
- Categories
- Medical & Healthcare Supplies, Supplements & Wellness
- Markets
- Singapore, Australia, United States, United Kingdom
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
- domain-registered (green), checked 2026-08-08 Domain registry record
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- certificate-page-on-site (amber), checked 2026-08-11 Company's own certification page
Claimed certifications
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)